These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31713727)

  • 1. VGF peptides as novel biomarkers in Parkinson's disease.
    Cocco C; Corda G; Lisci C; Noli B; Carta M; Brancia C; Manca E; Masala C; Marrosu F; Solla P; Manconi B; Bongioanni P; Ferri GL
    Cell Tissue Res; 2020 Jan; 379(1):93-107. PubMed ID: 31713727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VGF modifications related to nigrostriatal dopaminergic neurodegeneration induced by the pesticide fipronil in adult male rats.
    Manca E; Noli B; Corda G; El-Hassani M; Manai A; Sanna F; Argiolas A; Melis MR; Manconi B; Contini C; Cocco C
    Ann Anat; 2024 Feb; 252():152194. PubMed ID: 38056781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of VGF peptides in the human cortex and their selective changes in Parkinson's and Alzheimer's diseases.
    Cocco C; D'Amato F; Noli B; Ledda A; Brancia C; Bongioanni P; Ferri GL
    J Anat; 2010 Dec; 217(6):683-93. PubMed ID: 21039478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CART modulates the effects of levodopa in rat model of Parkinson's disease.
    Upadhya MA; Shelkar GP; Subhedar NK; Kokare DM
    Behav Brain Res; 2016 Mar; 301():262-72. PubMed ID: 26771081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VGF Peptide Profiles in Type 2 Diabetic Patients' Plasma and in Obese Mice.
    D'Amato F; Noli B; Angioni L; Cossu E; Incani M; Messana I; Manconi B; Solinas P; Isola R; Mariotti S; Ferri GL; Cocco C
    PLoS One; 2015; 10(11):e0142333. PubMed ID: 26562304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.
    Cheshire P; Ayton S; Bertram KL; Ling H; Li A; McLean C; Halliday GM; O'Sullivan SS; Revesz T; Finkelstein DI; Storey E; Williams DR
    Mov Disord; 2015 May; 30(6):796-804. PubMed ID: 25649148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease.
    Carriere CH; Kang NH; Niles LP
    Neuroscience; 2014 May; 267():114-21. PubMed ID: 24613722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levodopa induction of Fos immunoreactivity in rat brain following partial and complete lesions of the substantia nigra.
    Cole DG; Growdon JH; DiFiglia M
    Exp Neurol; 1993 Apr; 120(2):223-32. PubMed ID: 8491280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of combined assessment of olfaction and sustantia nigra hyperechogenicity for Parkinson's disease.
    López Hernández N; García Escrivá A; Shalabi Benavent M
    Neurologia; 2015 Oct; 30(8):496-501. PubMed ID: 24839905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective expression of TLQP-21 and other VGF peptides in gastric neuroendocrine cells and modulation by feeding.
    Brancia C; Cocco C; D'Amato F; Noli B; Sanna F; Possenti R; Argiolas A; Ferri GL
    J Endocrinol; 2010 Dec; 207(3):329-41. PubMed ID: 20876237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regenerative effects of peptide nanofibers in an experimental model of Parkinson's disease.
    Sever M; Turkyilmaz M; Sevinc C; Cakir A; Ocalan B; Cansev M; Guler MO; Tekinay AB
    Acta Biomater; 2016 Dec; 46():79-90. PubMed ID: 27619838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estrogen protects the dopaminergic neurons in substantia nigra against damage induced by 6-hydroxydopamine].
    Meng JL; Ma YY; Luo HY; Kong SZ; He YW; Dong BC; Wu SH; He M
    Sheng Li Xue Bao; 2008 Jun; 60(3):369-74. PubMed ID: 18560728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could VGF and/or its derived peptide act as biomarkers for the diagnosis of neurodegenerative diseases: A systematic review.
    Alqarni S; Alsebai M
    Front Endocrinol (Lausanne); 2022; 13():1032192. PubMed ID: 36619561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of M1/M2 polarization by capsaicin contributes to the survival of dopaminergic neurons in the lipopolysaccharide-lesioned substantia nigra in vivo.
    Bok E; Chung YC; Kim KS; Baik HH; Shin WH; Jin BK
    Exp Mol Med; 2018 Jul; 50(7):1-14. PubMed ID: 29968707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological characterization of substantia nigra dopaminergic neurons in partially lesioned rats: effects of subthalamotomy and levodopa treatment.
    Bilbao G; Ruiz-Ortega JA; Miguens N; Ulibarri I; Linazasoro G; Gómez-Urquijo S; Garibi J; Ugedo L
    Brain Res; 2006 Apr; 1084(1):175-84. PubMed ID: 16574080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
    Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
    Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-lesion administration of 7-NI attenuated motor and non-motor deficits in 6-OHDA induced bilaterally lesioned female rat model of Parkinson's disease.
    Kumari R; Kumar JB; Luthra PM
    Neurosci Lett; 2015 Mar; 589():191-5. PubMed ID: 25528406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.